Skip to main content
Equibles

Farther Finance Advisors, LLC

Position in RNAC — Cartesian Therapeutics, Inc.

CIK 1992825 SAN FRANCISCO, CA
Back to RNAC Full portfolio

Position in RNAC

as of Jun 30, 2026 · filed Jul 17, 2026
Position Value
$1,406
+$1,056 QoQ
Shares Held
135
+136.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#86
of 95 holders
Holding Since
Dec 2022
12 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in RNAC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Farther Finance Advisors, LLC holds $15,745,890 across 281 Biotechnology names. RNAC ranks #206 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 4,922 $2,444,905
2 MRNA
Moderna, Inc.
 15,429 $1,080,492
3 ARWR
Arrowhead Pharmaceuticals, Inc.
 12,088 $985,292
4 HALO
Halozyme Therapeutics, Inc.
 11,241 $879,833
5 EXEL
Exelixis, Inc.
 14,171 $771,044
6 REGN
Regeneron Pharmaceuticals, Inc.
 1,075 $670,305
7 VKTX
Viking Therapeutics, Inc.
 15,171 $591,820
8 BMRN
Biomarin Pharmaceutical Inc
 7,871 $450,378

All Filings in RNAC

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,406 135
2026-03-31 $350 57
2025-03-31 $7,104 539
2024-12-31 $322 18
2024-09-30 $290 18
2024-06-30 $486 18
2024-03-31 $350 539
2023-12-31 $742 1,078
2023-09-30 $571 539
2023-06-30 $603 539
2023-03-31 $749 539
2022-12-31 $609 539